Additional Effects of Sternocleidomastoid Release With SNAGS in the Management of Cervicogenic Headache
1 other identifier
interventional
38
1 country
1
Brief Summary
Cervicogenic headache is a common type of headache in adults which causes disability and difficulty in everyday activities. According to the latest International Headache Society model, cervicogenic headache (CGH) is a secondary headache having C1-C2 dysfunction. SNAGs are highly effective in the treatment approach for these patients. Sternocleidomastoid muscle receive overactive tension from forward neck posture, increasing muscular fatigue and tone of muscles. This tension in SCM causes referred pain in the head and neck region. SNAGs are very effective but musculoskeletal impairments especially the tightness of sternocleidomastoid muscle still persist and can exacerbate symptoms. Manual therapy targeted to the SCM muscle may be effective for reducing headache and neck pain intensity and increasing performance of deep cervical flexors. Findings of this study will aid the therapists in choosing which technique to use while treating the patients. This will save therapist's time and effort as they will not be using the less effective treatment protocol. Furthermore, patient's time and investment will be used in the right direction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2024
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedAugust 2, 2024
July 1, 2024
6 months
July 30, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Pain intensity
Pain will be measured on the basis of Numeric Pain Rating Scale score.
2 weeks
Range of motion
Cervical rotation will be measured through CROM device
2 weeks
Headache Disability
Headache Disability Index will be used
2 weeks
Cervical Proprioception
Joint Position Error Test will be used
2 weeks
Study Arms (2)
Conventional physical therapy Group
ACTIVE COMPARATORBoth Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache. * Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks. * TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks. In addition to this, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold. • Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Conventional physical therapy with sternocleidomastoid release
EXPERIMENTALBoth Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache. * Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks. * TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks. Headache SNAGs: In addition to the conventional physical therapy protocol, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold. * Frequency: 3 times a week for 2 weeks. 6 sessions in total. Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes. * Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Interventions
Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks. • TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold. • Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Eligibility Criteria
You may qualify if:
- Age group: 18-45 years old
- Both males and females
- Unilateral headache with no shift of side
- C1-C2 Dysfunction
- Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
- Headache at least once a month in the last 3 months
- Headache with at least 4 score in NPRS (Sign and Symptoms of Neck Involvement)
- Headache with restriction of ROM in the neck
- Headache precipitated by:
- Sustained neck movements, and awkward head positioning. External Pressure over upper cervical or occipital region
- Headache Characteristics:
- Moderate-severe, non-throbbing pain, usually starting in the neck.
- Episodes of varying duration, or: fluctuating, continuous pain
You may not qualify if:
- Headache of non-cervical origin
- Diagnosed Cases of:Cervical spondylosis,Cervical radiculopathy/ nerve root involvement/ disc herniation,Cervical instability/ fracture,Vertebrobasilar insufficiency ,Cervical spine surgery,Cervical spondylolisthesis,Spinal infection or tumors,Osteoporosis,History of trauma,Rheumatoid Arthritis,Inflammatory Arthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation University College of Physical Therapy
Rawalpindi, Punjab Province, 46000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 2, 2024
Study Start
June 10, 2024
Primary Completion
December 10, 2024
Study Completion
December 30, 2024
Last Updated
August 2, 2024
Record last verified: 2024-07